Assessment of palindromes as platforms for DNA amplification in breast cancer

Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Genome Research (Impact Factor: 14.63). 07/2011; 22(2):232-45. DOI: 10.1101/gr.117226.110
Source: PubMed


DNA amplification, particularly of chromosomes 8 and 11, occurs frequently in breast cancer and is a key factor in tumorigenesis, often associated with poor prognosis. The mechanisms involved in the amplification of these regions are not fully understood. Studies from model systems have demonstrated that palindrome formation can be an early step in DNA amplification, most notably seen in the breakage-fusion-bridge (BFB) cycle. Therefore, palindromes might be associated with gene amplicons in breast cancer. To address this possibility, we coupled high-resolution palindrome profiling by the Genome-wide Analysis of Palindrome Formation (GAPF) assay with genome-wide copy-number analyses on a set of breast cancer cell lines and primary tumors to spatially associate palindromes and copy-number gains. We identified GAPF-positive regions distributed nonrandomly throughout cell line and tumor genomes, often in clusters, and associated with copy-number gains. Commonly amplified regions in breast cancer, chromosomes 8q and 11q, had GAPF-positive regions flanking and throughout the copy-number gains. We also identified amplification-associated GAPF-positive regions at similar locations in subsets of breast cancers with similar characteristics (e.g., ERBB2 amplification). These shared positive regions offer the potential to evaluate the utility of palindromes as prognostic markers, particularly in premalignant breast lesions. Our results implicate palindrome formation in the amplification of regions with key roles in breast tumorigenesis, particularly in subsets of breast cancers.

Download full-text


Available from: Scott J Diede,
  • Source
    • "While this does not result in chromosomal instability being passed on to other chromosomes, it does lead to allelic imbalance, which is associated with cancer progression The above studies clearly demonstrate that B/F/B cycles resulting from telomere loss can generate many of the types of chromosome rearrangements commonly associated with human cancer. Evidence that B/F/B cycles are involved in human cancer is shown by the prominence of inverted repeats within amplified regions in human cancers (Ford and Fried, 1986; Guenthoer et al., 2011), which have been proposed to result from B/F/B cycles (Guenthoer et al., 2011). Cancer genome sequencing has also shown that inverted repeats are common in pancreatic cancer , leading to the proposal that telomere loss and B/F/B cycles play an important role in this disease (Campbell et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The ends of chromosomes in mammals, called telomeres, are composed of a 6-bp repeat sequence, TTAGGG, which is added on by the enzyme telomerase. In combination with a protein complex called shelterin, these telomeric repeat sequences form a cap that protects the ends of chromosomes. Due to insufficient telomerase expression, telomeres shorten gradually with each cell division in human somatic cells, which limits the number of times they can divide. The extensive cell division involved in cancer cell progression therefore requires that cancer cells must acquire the ability to maintain telomeres, either through expression of telomerase, or through an alternative mechanism involving recombination. It is commonly thought that the source of many chromosome rearrangements in cancer cells is a result of the extensive telomere shortening that occurs prior to the expression of telomerase. However, despite the expression of telomerase, tumor cells can continue to show chromosome instability due to telomere loss. Dysfunctional telomeres in cancer cells can result from oncogene-induced replication stress, which results in double-strand breaks (DSBs) at fragile sites, including telomeres. DSBs near telomeres are especially prone to chromosome rearrangements, because telomeric regions are deficient in DSB repair. The deficiency in DSB repair near telomeres is also an important mechanism for ionizing radiation-induced replicative senescence in normal human cells. In addition, DSBs near telomeres can result in chromosome instability in mouse embryonic stem cells, suggesting that telomere loss can contribute to heritable chromosome rearrangements. Consistent with this possibility, telomeric regions in humans are highly heterogeneous, and chromosome rearrangements near telomeres are commonly involved in human genetic disease. Understanding the mechanisms of telomere loss will therefore provide important insights into both human cancer and genetic disease.
    Frontiers in Oncology 10/2012; 2:135. DOI:10.3389/fonc.2012.00135
  • Source
    • "Large-scale sequencing efforts have demonstrated remarkable heterogeneity both within and between tumors and between primary tumors and metastases (Gonzalez-Angulo et al. 2011; Jensen et al. 2011; Turajlic et al. 2012). Furthermore, they have begun to elucidate the mechanisms underlying the genomic instability in tumors (Castellarin et al. 2012; Guenthoer et al. 2012; Hinoue et al. 2012; Kostic et al. 2012; Wang et al. 2012; Xiong et al. 2012; Xu et al. 2012). A concerted community effort will be necessary to translate the data generated by the TCGA and the ICGC and other sequencing efforts into the knowledge and wisdom that will be required to improve patient outcomes. "

    Genome Research 02/2012; 22(2):177-82. DOI:10.1101/gr.136044.111 · 14.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chromosome 16 contains multiple copy number variations (CNVs) that predispose to genomic disorders. Here, we differentiate pathogenic duplications of 16p11.2-p12.2 from microscopically similar euchromatic variants of 16p11.2. Patient 1 was a girl of 18 with autism, moderate intellectual disability, behavioural difficulties, dysmorphic features and a 7.71-Mb (megabase pair) duplication (16:21 521 005-29 233 146). Patient 2 had a 7.81-Mb duplication (16:21 382 561-29 191 527), speech delay and obsessional behaviour as a boy and, as an adult, short stature, macrocephaly and mild dysmorphism. The duplications contain 65 coding genes of which Polo-like kinase 1 (PLK1) has the highest likelihood of being haploinsufficient and, by implication, a triplosensitive gene. An additional 1.11-Mb CNV of 10q11.21 in Patient 1 was a possible modifier containing the G-protein-regulated inducer of neurite growth 2 (GPRIN2) gene. In contrast, the euchromatic variants in Patients 3 and 4 were amplifications from a 945-kb region containing non-functional immunoglobulin heavy chain (IGHV), hect domain pseudogene (HERC2P4) and TP53-inducible target gene 3 (TP53TG3) loci in proximal 16p11.2 (16:31 953 353-32 898 635). Paralogous pyrosequencing gave a total copy number of 3-8 in controls and 8 to >10 in Patients 3 and 4. The 16p11.2-p12.2 duplication syndrome is a recurrent genomic disorder with a variable phenotype including developmental delay, dysmorphic features, mild to severe intellectual disability, autism, obsessive or stereotyped behaviour, short stature and anomalies of the hands and fingers. It is important to differentiate pathogenic 16p11.2-p12.2 duplications from harmless, microscopically similar euchromatic variants of proximal 16p11.2, especially at prenatal diagnosis.European Journal of Human Genetics advance online publication, 25 July 2012; doi:10.1038/ejhg.2012.144.
    European journal of human genetics: EJHG 07/2012; 21(2). DOI:10.1038/ejhg.2012.144 · 4.35 Impact Factor
Show more